POP-OUT | CLOSE
 
Crystal Structure of HIV-1 Neutralizing Antibody CH04
Sequence Clustering and Redundancy Reduction Results
3TCL
Cluster # 3 Members. Sequence cutoff: 70% Cluster size: 1291 sequences | showing only first 1000 cluster members
Rank   PDB id Entity id Chains Description Details Taxonomy EC Number
Select for download / view details OR: Select two chains for comparison
  Download      Details  
1 4NZU 1 L 13PL heavy chain Fab 9606  
2 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090  
3 1MEX 1 L Fab 29G12 light chain 10090  
4 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090  
5 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090  
6 2XZC 2 L FAB A.17 LIGHT CHAIN 9606  
7 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090  
8 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090  
9 1RUK 1 L immunoglobulin igg2a, light chain fab 10090  
10 2VXV 2 L HUMAN IGG ABT-325 9606  
11 2VXT 3 L MURINE IGG 125-2H 10090  
12 1RUM 1 L immunoglobulin igg2a, light chain fab 10090  
13 2XZA 2 L FAB A.17 LIGHT CHAIN 9606  
14 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090  
15 3T65 2 A S25-2 FAB (IGG1K) light chain 10090  
16 4JG1 1 L Fab light chain 9606  
17 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606  
18 3IFL 1 L 12A11 FAB antibody light chain 10090  
19 3PP4 2 L GA101 Fab light chain 10090  
20 3KDM 1 A, L Immunoglobulin light chain 9606  
21 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
22 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
23 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090  
24 4HS6 2 A, L MRCT10.v362 Fab light chain 9606  
25 3IFN 2 L 12A11 FAB antibody light chain 10090  
26 3NPS 3 C S4 FAB LIGHT CHAIN 9606  
27 1RUR 1 L immunoglobulin 13G5, light chain fab 10090  
28 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090  
29 3NTC 1 L Fab light chain 10090  
30 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606  
31 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090  
32 4NZR 2 L PGT135 light chain Fab 9606  
33 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090  
34 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090  
35 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606  
36 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090  
37 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
38 3QQ9 1 C, L 101F LIGHT CHAIN 10090  
39 3OZ9 1 L Fab NC-1 kappa light chain 10090  
40 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606  
41 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606  
42 3G5Y 1 A 175 light chain 10090  
43 4HGW 1 A Antibody Fab fragment, light chain 10090  
44 1NLB 1 L antibody 19D9D6 light chain 10090  
45 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090  
46 3VFG 1 L 3F8 Light Chain 10090  
47 3QRG 1 L Fab light chain 9606  
48 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090  
49 4K23 2 L anti-uPAR antibody, light chain 10090  
50 3NCJ 1 L Fab15 Mut8 light chain 9606  
51 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
52 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090  
53 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090  
54 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
55 4M61 1 A, C Fab A52 light chain 10090  
56 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
57 1UM5 1 L Antibody 21H3 L chain 10090  
58 3WHX 2 B mAb Fab L fragment 10090  
59 3NA9 1 L Fab15 light chain 9606  
60 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
61 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
62 4LRI 1 A, B MSL-109 Light Chain 9606  
63 4JN2 1 A, L anti dabigatran Fab 10090  
64 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090  
65 4JFZ 1 L Fab light chain 9606  
66 3WIF 2 B mAb Fab L fragment 10090  
67 3MBX 1 L X836 LIGHT CHAIN 10090  
68 4HHA 1 A Fab KE5 Fab fragment KE5 9606  
69 3NAA 1 L Fab15 Mut5 light chain 9606  
70 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090  
71 4PUB 2 L DX-2930 LIGHT CHAIN 9606  
72 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090  
73 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
74 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090  
75 3UYR 2 L antibody Fab light chain 10090  
76 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090  
77 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090  
78 3OAZ 2 K, L Fab 2G12, light chain 9606  
79 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090  
80 1ZAN 1 L Fab AD11 Light Chain 10116  
81 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
82 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090  
83 4JG0 1 L Fab light chain 9606  
84 3EO0 1 A, C GC-1008 Fab Light Chain 10090  
85 4JHA 2 L D25 light chain 9606  
86 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
87 4DGV 2 L HCV1 Light Chain 9606  
88 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
89 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090  
90 1YNL 1 L Ig gamma light chain 10090  
91 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090  
92 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090  
93 4NUJ 1 A PGT152 light chain 9606  
94 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090  
95 1RUA 1 L immunoglobulin igg2a, light chain fab 10090  
96 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090  
97 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090  
98 4NUG 1 L PGT151 light chain 9606  
99 3IU4 2 L chP3 Fab light chain 10090  
100 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
101 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090  
102 1P7K 1 A, L antibody light chain FAB 10090  
103 3RVV 2 C 4C1 - light chain 10090  
104 3P0Y 3 L Fab DL11 light chain 9606  
105 2YPV 3 L FAB 12C1 10090  
106 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606  
107 3NAC 1 L Fab15 Mut7 light chain 9606  
108 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
109 1Q72 1 L Fab M82G2, Light chain 10090  
110 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090  
111 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090  
112 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
113 4DGY 2 L HCV1 Light Chain 9606  
114 3T77 1 A S25-2 FAB (IGG1K) light chain 10090  
115 3MXW 2 L 5E1 light chain 9606  
116 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630  
117 3EO9 1 L Efalizumab Fab fragment, light chain 9606  
118 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090  
119 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090  
120 3C6S 1 A, C, E, G Fab F22-4 light chain 10090  
121 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090  
122 4JM4 2 L PGT 135 Light Chain Fab 9606  
123 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090  
124 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090  
125 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090  
126 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606  
127 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606  
128 2FX7 1 L Fab 4E10 Light Chain 9606  
129 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606  
130 3WFH 2 B mAb Fab L fragment 10090  
131 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090  
132 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090  
133 3RVW 2 C 4C1 - light chain 10090  
134 3D85 1 A FAB of antibody 7G10, light chain light chain 9606  
135 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090  
136 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090  
137 4JN1 2 L anti-dabigatran Fab1, light chain 10090  
138 4G5Z 2 L canakinumab antibody fragment light chain 9606  
139 2OK0 2 L Fab ED10 light chain 10090  
140 3SOB 1 L antibody light chain 9606  
141 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090  
142 2IH3 2 B FAB Light Chain 10090  
143 4KQ3 1 L CNTO3186 light chain Fab 9606  
144 4JFX 1 A, L Fab light chain 9606  
145 3SGE 1 I, L Light Chain 10090  
146 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090  
147 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606  
148 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090  
149 1JGU 1 L Antibody Light Chain 10090  
150 4I77 2 L Lebrikizumab light chain Fab 9606  
151 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986  
152 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090  
153 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090  
154 4HJG 1 A Trastuzumab light chain 9606  
155 4M43 1 L Fragment antigen-binding 523-11 light chain 10090  
156 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
157 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
158 3FN0 1 L Fab Z13e1 light chain 9606  
159 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090  
160 1T2Q 1 L Fab NNA7 Heavy Chain 10090  
161 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090  
162 4MAU 1 L C2244 light chain SEE REMARK 999 10090  
163 3LEX 2 B, L 11f10 Antibody Light Chain 10090  
164 1OP3 1 K, L FAB 2G12, light chain light chain 9606  
165 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090  
166 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606  
167 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606  
168 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090  
169 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090  
170 4LKX 2 B Fab fragment light chain 9606  
171 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090  
172 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606  
173 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090  
174 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090  
175 2A77 1 L Immunoglobulin Light Chain 10090  
176 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090  
177 3QWO 1 B, L motavizumab light chain 10090  
178 3CVI 2 L 25-D1.16 Light chain 10090  
179 1PZ5 1 A Light chain of Fab (SYA/J6) 10090  
180 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116  
181 4IOI 1 A Trastuzumab light chain 9606  
182 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090  
183 4OKV 2 B, D light chain of 8H7 mAb 10090  
184 1JGV 1 L Antibody Light Chain 10090  
185 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090  
186 2ADF 3 L 82D6A3 IgG FAB 10090  
187 3O41 1 B, L Mouse monoclonal antibody 101F Fab light chain 10090  
188 1UM4 1 L Antibody 21H3 L chain 10090  
189 3I75 1 A Antibody heavy chain 10090  
190 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606  
191 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
192 1E6O 2 L IMMUNOGLOBULIN LIGHT CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') LIGHT CHAIN 1-210 10090  
193 1JFQ 1 L ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY LIGHT CHAIN 10090  
194 4H20 1 L Light chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090  
195 3OAY 1 K, L Fab 2G12, light chain 9606  
196 1CR9 1 L FAB ANTIBODY LIGHT CHAIN HEAVY CHAIN 10090  
197 1A3L 1 L IMMUNOGLOBULIN FAB 13G5 (LIGHT CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090  
198 1YEJ 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
199 4GMT 1 L, M Fab S139/1 light chain 10090  
200 3ZKM 3 D, L FAB LIGHT CHAIN 10090  
201 1FNS 1 L IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, LIGHT CHAIN 10090  
202 3HNS 2 L CS-35 Fab Light Chain Light Chain 10090  
203 1KEL 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
204 3TCL 2 B, L CH04 Light Chain Fab 9606  
205 3QOT 1 L B3 (IGKV4-1) light chain 9606  
206 1N0X 1 L, M IMMUNOGLOBULIN LIGHT CHAIN 9606  
207 2FAT 1 L FAB ATN-615, light chain 10090  
208 1RUL 1 L immunoglobulin igg2a, light chain fab 10090  
209 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606  
210 4H88 3 L POM1 FAB CHAIN L 10090  
211 1UM6 1 L antibody 21h3, L chain 10090  
212 2AK1 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
213 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090  
214 3HNV 2 L CS-35 Fab Light Chain Light Chain 10090  
215 3LEY 2 L 6a7 Antibody Light Chain 10090  
216 1YEI 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING DOMAIN 10090  
217 3QPQ 1 C, E, I, L C1068 light chain 10090  
218 2HFF 1 A, L CB2 Fab, light chain 9606  
219 4M7K 1 L 10H10 light chain SEE REMARK 999 10090  
220 1NDG 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-8 light chain 10090  
221 3OKD 1 A S25-39 Fab (IgG1k) light chain 10090  
222 2IPT 1 L IgG2a Fab fragment Heavy Chain 10090  
223 1SBS 2 L MONOCLONAL ANTIBODY 3A2 FAB FRAGMENT 10090  
224 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606  
225 4MA3 1 A, L C2095 light chain SEE REMARK 999 9986  
226 2FBJ 1 L IGA-KAPPA J539 FAB (LIGHT CHAIN) 10090  
227 1RUQ 1 L immunoglobulin 13G5 light chain fab 10090  
228 2HKF 1 L Immunoglobulin Light chain Fab fragment 10090  
229 1YEC 1 L IGG2A FAB FRAGMENT (D2.3) CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 10090  
230 6FAB 1 L IGG1-KAPPA 36-71 FAB (LIGHT CHAIN) 10090  
231 3L5X 1 L H2L6 LIGHT CHAIN 9606  
232 2YMX 2 L FAB ANTIBODY LIGHT CHAIN VARIABLE DOMAIN 10090  
233 2NXY 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
234 2R8S 2 L Fab light chain 10090  
235 4HKZ 1 A Trastuzumab light chain 9606  
236 1R3J 1 A Antibody Fab fragment light chain 10090  
237 1RIU 1 L Fab M82G2, Light Chain 10090  
238 3OKK 1 A S25-39 Fab (IgG1k) light chain 10090  
239 3BPC 1 A Fab, antibody fragment (IgG1k), light chain 10090  
240 3SO3 2 B A11 FAB light chain 9606  
241 3IDG 1 A 2F5 Fab light chain 9606  
242 2AJX 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
243 3RU8 3 L Antibody b12, Light Chain 9606  
244 1KN2 1 L IG ANTIBODY D2.3 (LIGHT CHAIN) 10090  
245 1KN4 1 L IG ANTIBODY D2.3 (LIGHT CHAIN) 10090  
246 3OAU 2 L Fab 2G12, light chain 9606  
247 2BRR 2 L, X MN20B9.34 ANTI-P1.4 ANTIBODY, FAB LIGHT CHAIN 10090  
248 3HZV 1 A S73-2 Fab (IgG1k) light chain 10090  
249 1NBZ 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090  
250 3LS5 1 L Light chain of antibody Fab fragment 10090  
251 3FO9 1 A, L Immunoglobulin IGG2A - light chain light chain of 33F12 Fab' fragment 10090  
252 1E4W 2 L TAB2 MURINE FAB-FRAGMENT IG KAPPA LIGHT CHAIN 10090  
253 3U0W 2 L Fab Light Chain, Ig kappa chain C region chimera of Fab Light Chain from mouse, Ig kappa chain C region from human 10090  
254 2O5X 1 L chimeric antibody Fab 1E9-DB3 light chain 10090  
255 4HIE 1 A Fab 023.102 9606  
256 1FL3 2 B, L BLUE FLUORESCENT ANTIBODY (19G2)-LIGHT CHAIN FAB FRAGMENT 10090  
257 4LEX 1 L FAB HEAVY CHAIN 10090  
258 3QEG 2 L Fab fragment of human anti-HIV antibody N12-i2, light chain Fab light chain 9606  
259 3SE9 3 L Light chain of antibody VRC-PG04 antibody light chain 9606  
260 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606  
261 3EYS 1 L If kappa light chain 10090  
262 3WE6 2 B mAb Fab L fragment 10090  
263 12E8 1 L, M IGG1-KAPPA 2E8 FAB (LIGHT CHAIN) FAB FRAGMENT 10090  
264 1A3R 1 L IGG2A 8F5 FAB (LIGHT CHAIN) FAB FRAGMENT (PAPAIN DIGESTION) 10090  
265 1HIL 1 A, C IGG2A-KAPPA 17/9 FAB (LIGHT CHAIN) 10090  
266 2NY2 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
267 1F58 1 L PROTEIN (IGG1 ANTIBODY 58.2 (LIGHT CHAIN)) 10090  
268 1QKZ 3 L ANTIBODY FAB 10090  
269 2G60 1 L anti-FLAG M2 Fab light chain 10090  
270 4KMT 1 L light chain O12/KAPPA Fab 9606  
271 2FR4 2 A, L antibody light chain FAB antigen-binding fragment 10090  
272 3NZH 1 L 5F6 LIGHT CHAIN 10090  
273 1RHH 1 A, C Fab X5, light chain 9606  
274 2Q76 1 A, C Fab F10.6.6 fragment Light Chain domain VL and CL 10090  
275 1TJG 1 L FAB 2F5 Light Chain 9606  
276 1YEF 1 L IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
277 1YEG 1 L IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
278 3IFO 2 B, L 10D5 FAB antibody light chain 10090  
279 4JPI 2 B, L Putative VRC01 germline Fab light chain 9606  
280 4M7J 2 L S25-26 Fab (Igg1k) light chain 10090  
281 1UYW 2 L, N FAB ANTIBODY LIGHT CHAIN 10090  
282 2XQY 3 K, L A13-D6.3 MONOCLONAL ANTIBODY LIGHT CHAIN OF FAB FRAGMENT 10090  
283 3O6K 1 L 11H6H1 Fab' light chain 10090  
284 3C5S 1 A, C Fab F22-4 light chain 10090  
285 1RZ7 1 L Fab 48d light chain 9606  
286 1RZG 2 B, D Fab 412d heavy chain 9606  
287 1GPO 1 L, M ANTIBODY M41 FAB FRAGMENT 10090  
288 3QOS 1 A, L B3 (IGKV4-1) light chain 9606  
289 2HVK 2 B Antibody Fab light chain 10090  
290 1MJJ 1 A, L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090  
291 3PGF 3 L SAB Light Chain 9606  
292 1IQD 1 A HUMAN MONOCLONAL BO2C11 FAB LIGHT CHAIN 9606  
293 1P2C 1 A, D light chain anti-lysozyme antibody F10.6.6 10090  
294 2NY4 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
295 1ORS 1 A 33H1 Fab light chain 10090  
296 1MLB 1 A IGG1-KAPPA D44.1 FAB (LIGHT CHAIN) 10090  
297 2ZKH 1 L Monoclonal TN1 FAB light chain 9606  
298 3OJD 1 A Fab V2D2 Light chain 10090  
299 2NY3 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
300 3ZKN 3 D, L FAB LIGHT CHAIN 10090  
301 1LO0 1 L, X If kappa light chain Fab fragment 10090  
302 35C8 1 L IGG 5C8 FAB 10090  
303 1MIE 1 L IMMUNOGLOBULIN MS5-393 Fab fragment, LIGHT CHAIN 10090  
304 4DVB 2 B, L Fab fragment of pro-uPA antibody mAb-112 10090  
305 1RFD 1 L Fab M82G2, Light Chain 10090  
306 2QQN 3 L Antibody light chain 9606  
307 3RVT 1 C Fab fragment of 4C1 antibody - light chain 10090  
308 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
309 2NY1 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
310 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606  
311 3EOT 2 L FAB FRAGMENT, LIGHT CHAIN 10090  
312 4MA7 3 L POM1 light chain Fab 10090  
313 1LO2 1 L, X If kappa light chain Fab fragment 10090  
314 1UZ6 1 E, L, M, V IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090  
315 2D03 1 L anti-glycophorin A type N immunoglobulin light chain 10090  
316 3UJT 2 L, M Ab-52 light chain Fab fragment 10090  
317 3O6L 1 L 11H6H1 Fab' light chain 10090  
318 3E8U 2 L Fab 106.3 light chain 10090  
319 1C5B 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090  
320 4JZN 2 B, D, P Anti-HCV E2 Fab HC84-1 light chain 9606  
321 2CMR 3 L D5 9606  
322 3GNM 1 L JAA-F11 Fab Antibody Fragment, Light Chain 10090  
323 2FD6 2 L L chain of Fab of ATN-615 anti-uPAR antibody 10090  
324 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606  
325 1TET 1 L IGG1 TE33 FAB (LIGHT CHAIN) 10090  
326 4BZ2 3 L FAB 2D73 LIGHT CHAIN 10090  
327 2AEP 3 L FAB light chain 10090  
328 4MSW 2 B ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
329 3GRW 2 L Fab light chain 9606  
330 3LS4 1 L Light chain of antibody Fab fragment 10090  
331 1D5I 1 L CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (LIGHT CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
332 1OSP 1 L FAB 184.1 10090  
333 1F8T 1 L ANTIBODY FAB FRAGMENT (LIGHT CHAIN) 10090  
334 4LSP 3 L LIGHT CHAIN OF ANTIBODY VRC-CH31 9606  
335 2R2H 1 A Fab, antibody fragment (IgG1k), light chain 10090  
336 1DQJ 1 A ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090  
337 1RIV 1 L Fab M82G2, Light Chain 10090  
338 3QCU 2 L, M LT3015 antibody Fab fragment, light chain 9606  
339 1Q9K 1 A S25-2 Fab (IgG1k) light chain Light Chain kappa 10090  
340 4OTX 1 L, M N203 light chain Fab 10090  
341 1K4C 2 B antibody Fab fragment light chain 10090  
342 2NXZ 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
343 1E4X 3 L, M TAB2 MURINE FAB-FRAGMENT IG KAPPA LIGHT CHAIN 10090  
344 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606  
345 3CLF 1 L Fab light chain 10090  
346 4HIX 2 L Humanized 3D6 Fab light chain 10090  
347 4LKC 1 A Fab fragment of PCSK9 antibody 9606  
348 1MHH 1 A, C Fab, light chain 10090  
349 4GW5 1 A, C Fab Light Chain 10090  
350 4OM1 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
351 4KZD 2 L BL3-6 Fab antibody, light chain 10090  
352 4HCR 2 L, N PF-547659 light chain 9606  
353 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606  
354 1C1E 1 L CATALYTIC ANTIBODY 1E9 (LIGHT CHAIN) FAB FRAGMENT 10090  
355 1TJH 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
356 1YEK 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
357 4HIH 1 A, C Fab 023.102 9606  
358 1D6V 1 L CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (LIGHT CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
359 1YY8 1 A, C Cetuximab Fab Light chain 10090  
360 4ONG 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090  
361 4ETQ 2 B, L anti-vaccinia D8L antigen murine monoclonal IgG2a antibody LA5, light chain Fab 10090  
362 3QPX 1 L Fab C2507 light chain 10116  
363 2R0Z 1 L IgG2a Fab fragment light chain light chain 10090  
364 3DRQ 1 A 2F5 Fab' light chain 9606  
365 3NIG 4 F, L Monoclonal antibody 10E5 light chain 10090  
366 1TJI 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
367 1KEM 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
368 25C8 1 L IGG 5C8 FAB 10090  
369 3QNX 1 A Fab fragment of IMMUNOGLOBULIN A1 LIGHT CHAIN 9606  
370 3PHQ 1 A S64-4 Fab (IgG1) light chain 10090  
371 3G5V 1 A 806 light chain 10090  
372 4OLZ 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
373 3D0V 1 A 2F5 Fab heavy chain 9606  
374 2C1P 1 A, L IGK-C PROTEIN 10090  
375 4O51 1 A, C, E, L QAA-2095-2 light chain 9986  
376 3S34 1 L 1121B Fab light chain 10090  
377 1GAF 1 L CHIMERIC 48G7 FAB BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY CHAIN CONSISTS OF THE VDJ VARIABLE DOMAIN FROM MOUSE AND THE C(H1) CONSTANT REGION FROM HUMAN VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606  
378 2P7T 2 B FAB-B 10090  
379 3MOD 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
380 4HXA 1 L 13D9 FAB LIGHT CHAIN 10090  
381 1NDM 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-26 light chain 10090  
382 2IQA 1 A, L IgG2a Fab fragment PFA2 Kappa light chain 10090  
383 1H0D 1 A ANTIBODY FAB FRAGMENT, LIGHT CHAIN HINGE REGION OBSERVED IN THE FAB FRAGMENT 9606  
384 2F5B 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606  
385 3MNW 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and human Fc 10090  
386 1IL1 2 B monoclonal antibody G3-519 (light chain) FAB FRAGMENT 10090  
387 1U8I 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
388 2VDR 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
389 2RCS 1 L IMMUNOGLOBULIN 48G7 GERMLINE FAB VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 10090  
390 1JGL 1 L Ig kappa-chain 10090  
391 4G6J 3 L light chain of antibody binding fragment of canakinumab light chain of antibody binding fragment of canakinumab 9606  
392 2AJ3 1 A, C, E Fab m18, Light Chain 9606  
393 1SY6 1 L OKT3 Fab light chain fab fragment light chain 10090  
394 3T3P 4 F, L Monoclonal antibody 10E5 light chain 10090  
395 1EMT 1 L IGG ANTIBODY (LIGHT CHAIN) FAB FRAGMENT 10090  
396 3IDI 1 A 2F5 Fab light chain 9606  
397 1CLO 1 L A5B7 MONOCLONAL ANTIBODY ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7 ANTIGEN BINDING FRAGMENT, FAB 10090  
398 3PNW 1 A, D, G, J, M, P, S, V FAB light chain 32630  
399 1FE8 3 L, M, N IMMUNOGLOBULIN IGG RU5 FAB FRAGMENT LIGHT CHAIN 10090  
400 3QO0 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606  
401 4NRX 3 B, E, L m66 Light Chain 9606  
402 2Y5T 2 B CIIC1 FAB FRAGMENT LIGHT CHAIN DISULFIDE BRIDGE BETWEEN B23 AND B92, B138 AND B198 10090  
403 1L7T 1 L anti-testosterone (light chain) fab77 fragment 10090  
404 3O2D 1 L ibalizumab light chain 10090  
405 4GW1 1 A, C Fab light chain 10090  
406 3HI6 3 L, Y light chain of Fab fragment of AL-57 against alpha L I domain 9606  
407 3IJH 1 A, C Immunoglobulin light chain (IGG3) 10090  
408 1XGP 1 A antibody kappa light chain 10090  
409 2VL5 2 B, D CIIC1 ANTICOLLAGEN FAB 10090  
410 1YNK 1 L immunoglobulin kappa light chain 10090  
411 1DQD 1 L FAB HGR-2 F6 LIGHT CHAIN 10090  
412 1AJ7 1 L IMMUNOGLOBULIN 48G7 FAB (LIGHT CHAIN) VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 10090  
413 2R0L 1 L antibody light chain 32630  
414 4M93 1 C, L S25-26 Fab (IgG1k) light chain 10090  
415 1DN0 1 A, C IGM-KAPPA COLD AGGLUTININ (LIGHT CHAIN) FAB FRAGMENT 9606  
416 2PCP 1 A, C IMMUNOGLOBULIN COMPLEXED WITH 1-(1-PHENYLCYCLOHEXYL) PIPERIDINE (PCP, OR PHENCYCLIDINE) FAB 10090  
417 1AY1 1 L TP7 FAB FAB 10090  
418 1MH5 1 A, L IMMUNOGLOBULIN MS6-164 Fab fragment, LIGHT CHAIN 10090  
419 4MA8 3 L POM1 light chain Fab 10090  
420 4P9M 1 L 8ANC195 light chain 8ANC195 LIGHT CHAIN 9606  
421 3SGD 1 I, L Light Chain 10090  
422 3HZY 1 A S73-2 Fab (IgG1k) light chain 10090  
423 3GIZ 1 L Fab fragment of anti-CD20 antibody Ofatumumab, light chain 9606  
424 2HRP 1 L, M MONOCLONAL ANTIBODY F11.2.32 FAB FRAGMENT 10090  
425 3QNZ 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606  
426 1I8M 3 A, L ANTIBODY LIGHT CHAIN FAB 10090  
427 3NID 4 F, L Monoclonal antibody 10E5 light chain 10090  
428 3Q1S 1 L Z13e1 Fab light chain 9606  
429 1U8H 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
430 3FO2 1 A, L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090  
431 1KCU 1 L PC287 IMMUNOGLOBULIN light chain 10090  
432 2CK0 1 L PROTEIN (IMMUNOGLOBULIN; LIGHT CHAIN) IGG1, KAPPA FAB FRAGMENT 10090  
433 1AXT 1 L IMMUNOGLOBULIN IGG2A FAB' FRAGMENT 33F12 10090  
434 1VPO 1 L anti-testosterone (light chain) fab77 fragment 10090  
435 1NBV 1 L IGG2B-KAPPA BV04-01 FAB (LIGHT CHAIN) 10090  
436 4IMK 2 C, D Light Chain 9606  
437 1OAK 1 L NMC-4 IGG1 THE ANTIBODY HEAVY CHAIN CONSISTS OF TWO SEGMENTS, H1 AND H2, BOTH LABELED CHAIN H IN THIS ENTRY FAB FRAGMENT, AN ANTI VON WILLEBRAND FACTOR (VWF) A1 DOMAIN 10090  
438 1XGU 1 A antibody kappa light chain 10090  
439 4JZO 2 B, E, F, H Anti-HCV E2 Fab HC84-27 light chain 9606  
440 2F5A 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606  
441 4OLU 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
442 3KR3 3 L antibody-Fab (light chain) 9606  
443 2HKH 1 L Immunoglobulin Light chain Fab fragment 10090  
444 1UB5 2 B, L antibody 19G2, beta chain 10090  
445 4KVC 2 L Ig kappa chain V-V region MOPC 21, Anti-colorectal carcinoma light chain 10090  
446 4OLX 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
447 2AJY 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
448 1DQM 1 L ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090  
449 1YEE 1 L IGG2A FAB FRAGMENT (D2.5) TRANSITION STATE ANALOGUE 10090  
450 1QBL 1 L FABE8A IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090  
451 2NY0 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
452 4LSQ 3 L LIGHT CHAIN OF ANTIBODY VRC-CH31 WITH N70D MUTATION 9606  
453 3ZE2 4 F, L 10E5 FAB LIGHT CHAIN 10090  
454 4LVO 2 B NIMP.M7 Fab light chain 10090  
455 3MOA 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
456 2VDO 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
457 3S35 2 L 6.64 Fab light chain 10090  
458 3HZK 1 A S73-2 Fab (IgG1k) light chain 10090  
459 3QO1 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606  
460 3OKN 1 A S25-39 Fab (IgG1k) light chain 10090  
461 2PR4 1 L nmAb 2F5 Fab' Heavy Chain 9606  
462 4D9Q 2 D, L Anti-Factor D, light chain 9606  
463 1A4J 1 A, L IMMUNOGLOBULIN, DIELS ALDER CATALYTIC ANTIBODY (LIGHT CHAIN) FAB 10090  
464 3QNY 1 A, C FAB FRAGMENT OF IMMUNOGLOBULIN A1 LIGHT CHAIN 9606  
465 4LVN 2 B NIMP.M7 Fab light chain 10090  
466 3VG0 1 L Monoclonal antibody 9F8 Fab fragment L chain 10090  
467 1BGX 2 L TP7 MAB FAB 10090  
468 1YYM 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606  
469 3ZDX 4 F, L 10E5 FAB, LIGHT CHAIN 10090  
470 3DGG 1 A, C FabOX108 Light Chain Fragment 9606  
471 1MJ7 1 L IMMUNOGLOBULIN MS5-393 Fab fragment, LIGHT CHAIN 10090  
472 2Z4Q 1 A anti egfr antibody fab, light chain 10090  
473 1CT8 1 A, C 7C8 FAB FRAGMENT; SHORT CHAIN 10090  
474 1FL5 1 A, L ANTIBODY GERMLINE PRECURSOR TO ANTIBODY 28B4 LIGHT CHAIN (CHAINS L AND A) 10090  
475 2VDQ 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
476 2O5Z 1 L chimeric antibody Fab 1E9-DB3 light chain 10090  
477 4OM0 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
478 1MRE 1 L IGG2B-KAPPA JEL103 FAB (LIGHT CHAIN) 10090  
479 3AAZ 2 B, L Humanized recombinant Fab fragment of a murine; antibody 9606  
480 3WFD 1 L antibody fab fragment light chain 10090  
481 1XGQ 1 A antibody kappa light chain 10090  
482 3O2V 1 L Chimeric antibody Fab 1E9, light chain 10090  
483 3NIF 4 F, L Monoclonal antibody 10E5 light chain 10090  
484 4LSR 3 L LIGHT CHAIN OF ANTIBODY VRC-CH31 (N70D MUTATION) 9606  
485 2I5Y 2 L, Q Antibody 17B Light chain ANTIGEN-BINDING FRAGMENT, FAB 9606  
486 2CGR 1 L IGG2B-KAPPA NC6.8 FAB (LIGHT CHAIN) 10090  
487 2FX9 1 L, M Fab 4E10 Light Chain 9606  
488 4BZ1 3 L FAB 3E31 LIGHT CHAIN 10090  
489 1MRD 1 L IGG2B-KAPPA JEL103 FAB (LIGHT CHAIN) 10090  
490 3C08 1 L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090  
491 2NY7 3 L ANTIBODY b12, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
492 3U1S 1 L Fab PGT145 Light chain fragment antigen binding 9606  
493 1BZ7 1 A PROTEIN (ANTIBODY R24 (LIGHT CHAIN)) FAB 10090  
494 1TZG 1 L, M Fab 4E10 light chain 9606  
495 3W9D 2 B, D Antibody Fab light chain 9606  
496 2VXU 2 L, M MURINE IGG 125-2H 10090  
497 1U95 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
498 1IKF 1 L IGG1-KAPPA R45-45-11 FAB (LIGHT CHAIN) 9606  
499 4LQF 3 L Murine IgG2b A2C7 Light chain Fab domain 10090  
500 4NRZ 2 B, L M66.6 LIGHT CHAIN Fab Light Chain 9606  
501 1NCB 2 L IGG2A-KAPPA NC41 FAB (LIGHT CHAIN) 10090  
502 3BN9 2 C, E E2 Fab Light Chain 9606  
503 3MNV 1 A, C ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
504 3GK8 1 L Fab 14 Light Chain 10090  
505 4HWE 2 L Fab light chain light chain 9606  
506 4AEI 3 L, M, N FAB ANTIBODY LIGHT CHAIN VARIABLE DOMAIN 10090  
507 1MRF 1 L IGG2B-KAPPA JEL103 FAB (LIGHT CHAIN) 10090  
508 2AI0 1 L, M, N, O Immunoglobulin Light Chain kappa 10090  
509 1S5H 1 A ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
510 1IQW 1 L ANTIBODY M-HFE7A, LIGHT CHAIN FAB FRAGMENT 10090  
511 1A0Q 1 L 29G11 FAB (LIGHT CHAIN) PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL]PHOSPHONATE HAPTEN FAB 10090  
512 1U8K 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
513 1XF2 2 A, L antibody light chain Fab 10090  
514 3MCK 1 A, L C705 MONOCLONAL LIGHT CHAIN 10090  
515 1T66 1 C, L immunoglobulin light chain FAB 10090  
516 2H1P 1 L 2H1 FAB 10090  
517 1EAP 1 A IGG2B-KAPPA 17E8 FAB (LIGHT CHAIN) 10090  
518 4OCX 2 L Fab ADD056 Light Chain 10090  
519 1UWX 3 K, L ANTIBODY RESIDUES 3-214 (FAB FRAGMENT, LIGHT CHAIN) 10090  
520 3L95 1 A, L anti-NRR1 fab fragment light chain 9606  
521 3V0V 1 B, L WN1 222-5 Fab (IgG2a) light chain 10090  
522 4OGX 3 L DX-2930 LIGHT CHAIN 9606  
523 3W9E 3 B Antibody Fab light chain 9606  
524 3UTZ 1 A, D, E Metalloproteinase 10090  
525 1QBM 1 L E8B ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB FRAGMENT 10090  
526 1OM3 1 L, M FAB 2G12, light chain light chain 9606  
527 4KZE 2 L BL3-6 Fab antibody, light chain 10090  
528 3WKM 3 L, M MOUSE IGG1-KAPPA FAB (LIGHT CHAIN) 10090  
529 4HIJ 1 A, C Fab 023.102 light chain 9606  
530 1LO3 1 L, X If kappa light chain Fab fragment 10090  
531 3FO1 1 A, L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090  
532 1XGR 1 A antibody kappa light chain 10090  
533 3ZDY 4 F, L 10E5 FAB LIGHT CHAIN 10090  
534 1MRC 1 L IGG2B-KAPPA JEL103 FAB (LIGHT CHAIN) 10090  
535 3IET 1 A, C Immunoglobulin light chain (IgG2a) 10090  
536 1XF3 1 A, L Fab Light chain 10090  
537 2BMK 1 A, L FAB FRAGMENT OF CATALYTIC ANTIBODY 15A9, LIGHT CHAIN 10090  
538 3QCT 2 L LT3015 antibody Fab fragment, light chain 9606  
539 3EYF 1 A, C 8f9 Fab 9606  
540 3NAB 1 L Fab15 Mut6 light chain 9606  
541 3IDN 1 A 2F5 Fab light chain 9606  
542 1XGT 1 A antibody kappa light chain 10090  
543 1IGJ 1 A, C IGG2A-KAPPA 26-10 FAB (LIGHT CHAIN) 10090  
544 2Q8B 2 L 1F9 light chain 10090  
545 1RZ8 1 A, C Fab 17b light chain 9606  
546 1Q9L 2 A, C S25-2 Fab (IgG1k) light chain Fab Light chain kappa 10090  
547 4UUJ 2 B ANTIBODY FAB FRAGMENT HEAVY CHAIN 10090  
548 4OLY 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
549 4FNL 2 L, M Antibody C05, Light Chain 9606  
550 2DTM 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
551 1U92 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
552 1CIC 1 A PROTEIN (IG HEAVY CHAIN V REGIONS) FAB IMMUNOGLOBULIN FRAGMENT 10090  
553 1CIC 3 C PROTEIN (IG HEAVY CHAIN V REGIONS) FAB IMMUNOGLOBULIN FRAGMENT 10090  
554 1FVD 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606  
555 1C5D 1 A, L MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR FAB FRAGMENT, HEAVY CHAIN 10116  
556 1BJ1 1 J, L FAB FRAGMENT HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 10090  
557 1U91 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
558 2IQ9 1 L IgG2a Fab fragment PFA2 Kappa light chain 10090  
559 1F90 1 L FAB FRAGMENT OF MONOCLONAL ANTIBODY 10090  
560 3RVX 2 C 4C1 - light chain 10090  
561 2FX8 1 L, M, N, O Fab 4E10 Light Chain 9606  
562 1NGY 1 A Mature Metal Chelatase Catalytic Antibody, Light chain Fab fragment 10090  
563 4G6A 3 D, L AP33 Light chain antibody Fab 9606  
564 1M7D 1 A light chain of the monoclonal antibody Fab SYA/J6 10090  
565 3IDX 3 L Fab b13 light chain 9606  
566 1U8Q 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
567 1EHL 2 L ANTI-(6-4) PHOTOPRODUCT ANTIBODY 64M-2 FAB (LIGHT CHAIN) 10090  
568 2VDL 4 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
569 3IDJ 1 A 2F5 Fab light chain 9606  
570 3IDM 1 A 2F5 Fab light chain 9606  
571 1U8J 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
572 1ZLV 1 K, L FAB 2G12, light chain FAB, Light Chain 9606  
573 4K94 1 L Fab19 heavy chain 9606  
574 1K4D 2 B antibody Fab fragment light chain 10090  
575 1IGC 1 L IGG1-KAPPA MOPC21 FAB (LIGHT CHAIN) 10090  
576 1ZLS 1 L FAB 2G12, light chain FAB, Light Chain 9606  
577 4L5F 3 L Light chain of E106 antibody (kappa) VL anD CL domains 10090  
578 1RIH 1 L light chain of antibody 14F7 Fab 10090  
579 1MLC 1 A, C IGG1-KAPPA D44.1 FAB (LIGHT CHAIN) 10090  
580 1FDL 1 L IGG1-KAPPA D1.3 FAB (LIGHT CHAIN) 10090  
581 3V6F 2 B, D, F, L Fab e6 Light Chain 10090  
582 2W65 2 B, D ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090  
583 1I7Z 1 A, C CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION THE CHIMERA CONSISTS OF RESIDUES 1-108 OF MOUSE PORTION AND 109-214 OF HUMAN PORTION OF IG KAPPA CHAIN. 10090  
584 4KI5 2 D MURINE MONOCLONAL 3E6 FAB LIGHT CHAIN 10090  
585 4KI5 4 F MURINE MONOCLONAL G99 FAB LIGHT CHAIN 10090  
586 3D0L 1 A 2F5 heavy chain 9606  
587 4JPK 2 L Putative VRC01 germline precursor Fab light chain 9606  
588 3QG6 1 A, L AP4-24H11 Light Chain 10090  
589 4NX3 3 A Mouse Fab Light Chain 10090  
590 2B2X 3 L, M Antibody AQC2 Fab AQC2 Fab Light Chain 10090  
591 1XF4 1 A, L Fab light chain 10090  
592 2W0F 2 B ANTIBODY FAB FRAGMENT HEAVY CHAIN 10090  
593 2HFE 2 B FAB Light Chain 10090  
594 4HT1 3 L chimeric antibody Fab 9986  
595 2Q8A 2 L 1F9 light chain 10090  
596 4U0R 3 C Monoclonal antibody 9AD4 light chain 9986  
597 2JK5 2 B ANTIBODY FAB FRAGMENT HEAVY CHAIN 10090  
598 2H8P 2 B FAB light chain 10090  
599 1YEH 1 L FAB FRAGMENT IG GAMMA-2A CHAIN C REGION (D2.3) 10090  
600 3WFE 1 L antibody fab fragment light chain 10090  
601 3FCT 1 A, C PROTEIN (METAL CHELATASE CATALYTIC ANTIBODY) CHIMERIC FAB FRAGMENT FAB FRAGMENT 9606  
602 2J4W 3 L FAB FRAGMENT OF MONOCLONAL ANTIBODY F8.12.19 MONOCLONAL ANTIBODY ISOTYPE IS IGG1, KAPPA 10090  
603 15C8 1 L IGG 5C8 FAB (LIGHT CHAIN) FAB 10090  
604 1KEG 2 L Anti-(6-4) photoproduct antibody 64M-2 Fab (light chain) 10090  
605 1NCA 2 L IGG2A-KAPPA NC41 FAB (LIGHT CHAIN) 10090  
606 2P8L 1 A nmAb 2F5, light chain 9606  
607 1CZ8 2 L, X LIGHT CHAIN OF NEUTRALIZING ANTIBODY MUTATED FORM OF A HUMANIZED MURINE ANTIBODY LIGHT CHAIN FAB FRAGMENT 10090  
608 1RU9 1 L immunoglobulin igg2a, light chain fab 10090  
609 1CK0 1 L PROTEIN (IGG1-KAPPA ANTIBODY 131 (LIGHT CHAIN)) FAB 10090  
610 1UB6 2 B, L antibody 19G2, beta chain 10090  
611 4HXB 1 L 6B9 FAB LIGHT CHAIN 10090  
612 3WFC 1 L antibody fab fragment light chain 10090  
613 3R06 1 A, C, E, L anti-mouse CD3epsilon antibody 2C11 Fab light chain 10032  
614 1WC7 1 A, L FAB FRAGMENT OF CATALYTIC ANTIBODY 15A9, LIGHT CHAIN 10090  
615 3G5X 1 A, C 806 light chain 10090  
616 2Z92 2 B Anti-ciguatoxin antibody 10C9 Fab light chain 10090  
617 1A4K 1 A, L ANTIBODY FAB FAB 10090  
618 1CF8 1 L PROTEIN (CATALYTIC ANTIBODY 19A4 (LIGHT CHAIN)) FAB, VARIABLE REGION 10090  
619 3T3M 4 F, L Monoclonal antibody 10E5 light chain 10090  
620 1KC5 1 L PC287 Immunoglobulin light chain 10090  
621 4I2X 1 A, C FabOX117 light chain 9606  
622 3HR5 1 A, L, P, Q Fab h47H4 light chain 10090  
623 4K2U 3 L, M Antibody Light Chain 10090  
624 3O6M 1 L 11H6H1 Fab' light chain 10090  
625 2I60 2 L, Q ANTIBODY 17B LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
626 1A6T 1 A, C IGG1 FAB1-IA FAB (LIGHT CHAIN) FAB FRAGMENT 10090  
627 2G5B 1 A, C, E, G 6A7 Fab Light Chain 10090  
628 4EDW 2 L tanezumab Fab light chain 9606  
629 2DDQ 2 L R310 antibody light chain 10090  
630 4MA1 2 C, F, L S25-26 Fab (IgG1k) light chain 10090  
631 1UCB 1 L CHIMERIC HUMAN/MOUSE IGG FAB FRAGMENT BR96 MOUSE VH AND VL DOMAINS, HUMAN CL KAPPA AND CH1 IGG1 DOMAINS 9606  
632 1FVE 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606  
633 2NY5 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
634 4NM4 1 L, M Antibody CR8043, Light Chain 9606  
635 4LST 3 L LIGHT CHAIN OF ANTIBODY VRC01 9606  
636 2VDP 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
637 3U7Y 3 L NIH45-46 light chain, Ig kappa chain C region 9606  
638 1U8M 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
639 1R3I 1 L Antibody Fab fragment light chain 10090  
640 4D9R 2 D, L Fab light chain 9606  
641 4F3F 1 A MORAb-009 Fab light chain 10090  
642 3U7W 2 L Light chain, Ig kappa chain C region 9606  
643 2H9G 1 A, L Fab BdF1, light chain Fab fragment 9606  
644 4G7V 2 L fragment antibody light chain 9606  
645 2ADG 1 A Q425 Fab Light chain 10090  
646 4HDI 1 A, L Kappa light chain variable region, Anti-colorectal carcinoma light chain 10090  
647 2AJZ 1 A, L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
648 1I9J 1 L RECOMBINANT MONOCLONAL ANTI-TESTOSTERONE FAB FRAGMENT LIGHT CHAIN 10090  
649 4HFW 1 A, L 6-26 Fab Light chain 9606  
650 3L7E 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
651 1Y0L 1 A, C, E, L Catalytic Antibody Fab 34E4 Light chain THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE. 10090  
652 2XRA 3 L HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN 9606  
653 4LIQ 3 L Fab fragment RG7155 light chain Humanized Version of a monoclonal murine. 10090  
654 4KQ4 1 L CNTO7357 light chain Fab (mouse variable domain, human constant domain) 10090  
655 3INU 2 L, N KZ52 antibody fragment light chain 9606  
656 3OKO 2 A S25-39 Fab (IgG1k) heavy chain 10090  
657 1R3L 1 A Antibody Fab fragment light chain 10090  
658 3DIF 1 A, C FabOX117 Light Chain Fragment 9606  
659 4NCC 1 1, L Fab fragment light 10090  
660 4LBE 2 B Fab heavy chain 10090  
661 4PB9 2 L Ab64 light chain 10090  
662 3LEV 2 L 2F5 ANTIBODY LIGHT CHAIN 9606  
663 2VQ1 1 A, E IGKV1-117 PROTEIN ANTIGEN BINDING FRAGMENT 10090  
664 4OLV 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
665 1RJL 1 A Fab H6831 L-chain 10090  
666 1BQL 1 L HYHEL-5 FAB (LIGHT CHAIN) 10090  
667 2ORB 1 L, M Monoclonal anti-c-myc antibody 9E10 light chain of antigen binding fragment, Fab 10090  
668 1IGI 1 L IGG2A-KAPPA 26-10 FAB (LIGHT CHAIN) 10090  
669 1DFB 1 L IGG1-KAPPA 3D6 FAB (LIGHT CHAIN) 9606  
670 4G3Y 1 L infliximab Fab L 9606  
671 1MAM 1 L IGG2B-KAPPA YST9.1 FAB (LIGHT CHAIN) 10090  
672 2VDK 4 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
673 1PLG 1 L IGG2A=KAPPA= FAB FRAGMENT THAT BINDS POLYSIALIC ACID 10090  
674 2EH7 1 L HUMANIZED KR127 FAB, LIGHT CHAIN 10090  
675 1BFO 1 A, C, E, G CAMPATH-1G ANTIBODY FAB FRAGMENT 10117  
676 1RZJ 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606  
677 3OKE 1 A S25-39 Fab (IgG1k) light chain 10090  
678 4HII 1 A, C Fab 023.102 light chain 9606  
679 1K6Q 1 L immunoglobulin Fab D3, light chain Fab fragment 10090  
680 2EH8 1 L HUMANIZED KR127 FAB, LIGHT CHAIN 10090  
681 1KCS 1 L PC282 IMMUNOGLOBULIN light chain 10090  
682 1AD0 1 A, C ANTIBODY A5B7 (LIGHT CHAIN) FAB FRAGMENT 9606  
683 4DN3 1 L CNTO888 LIGHT CHAIN 9606  
684 4U6V 2 L, M Fab, antigen binding fragment, light chain 9606  
685 4LSS 3 L LIGHT CHAIN OF ANTIBODY VRC01 with N72T mutation 9606  
686 4EDX 2 A, L light chain of FAB of murine anti-NGF 10090  
687 1MPA 1 L MN12H2 IGG2A-KAPPA FAB FRAGMENT 10090  
688 3IF1 1 A, C Immunoglobulin light chain (IgG2a) 10090  
689 2XA8 2 L OMALIZUMAB LIGHT CHAIN 9606  
690 4JFY 1 A, L Fab light chain 9606  
691 3MOB 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
692 3EYV 1 A, L hu3S193 Fab, light chain 10090  
693 2JEL 1 L JEL42 FAB FRAGMENT 10090  
694 1GC1 3 L ANTIBODY 17B MONOCLONAL ANTIBODY 17B BINDS TO A CD4-INDUCED SITE ON GP120 ANTIGEN-BINDING FRAGMENT, FAB 9606  
695 3STL 2 B antibody Fab fragment light chain 10090  
696 1FOR 1 L IGG2A-KAPPA 17-IA FAB (LIGHT CHAIN) 10090  
697 1HKL 1 L 48G7 FAB VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606  
698 3EYU 1 L If kappa light chain 10090  
699 3PP3 2 K, L GA101 Fab light chain 10090  
700 1MIM 1 L CHIMERIC SDZ CHI621 MURINE ANTI-CD25 MONOCLONAL ANTIBODY, RFT5, CHIMERIZED WITH THE CONSTANT REGIONS OF HUMAN 1GG1 HEAVY AND KAPPA LIGHT CHAINS IGG FAB 9606  
701 2R0W 1 L IgG2a Fab fragment light chain light chain 10090  
702 3CFD 1 A, L PURPLE-FLUORESCENT ANTIBODY EP2-25C10-KAPPA LIGHT CHAIN FAB 10090  
703 1NCC 2 L IGG2A-KAPPA NC41 FAB (LIGHT CHAIN) 10090  
704 1NCD 2 L IGG2A-KAPPA NC41 FAB (LIGHT CHAIN) 10090  
705 3BDY 2 L Fab Fragment -Light Chain 9606  
706 1IFH 1 L IGG2A-KAPPA 17/9 FAB (LIGHT CHAIN) 10090  
707 2UYL 1 A, M, V, X MONOCLONAL ANTIBODY F-22-30 10090  
708 3FZU 1 D, L immunoglobulin IgG1 Fab, light chain 9606  
709 1G9M 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
710 1EJO 1 L IGG2A MONOCLONAL ANTIBODY (LIGHT CHAIN) FAB FRAGMENT 10090  
711 4J8R 1 A, C Light chain of POM2 Fab unp residues 67-82 10090  
712 3CMO 1 L, X Fab light chain 10090  
713 3K2U 4 L Antibody, Fab fragment, Light Chain 9606  
714 4BH8 1 A ANTI-ARS MURINE GERMLINE MONOCLONAL ANTIBODY 36-65 ANTIGEN BINDING FRAGMENT 10090  
715 4PB0 2 L Ab53 light chain 10090  
716 3RVU 1 C 4C1 Fab - light chain 10090  
717 1CU4 1 L FAB LIGHT CHAIN FAB ANTIBODY 3F4, LIGHT CHAIN 10090  
718 1U8N 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
719 4HWB 3 L Fab light chain 9606  
720 1CBV 2 L PROTEIN (FAB (BV04-01) AUTOANTIBODY-LIGHT CHAIN) 10090  
721 1AXS 1 A, L OXY-COPE CATALYTIC ANTIBODY CHIMERIC FAB FRAGMENT FAB FRAGMENT 9606  
722 3OKM 1 A S25-39 Fab (IgG1k) light chain 10090  
723 1U93 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
724 2IH1 2 B FAB Light Chain 10090  
725 1XF5 2 A, C Monoclonal antibody 19D9D6 Light chain 10090  
726 3O2W 1 L Chimeric antibody Fab 1E9, light chain 10090  
727 1PG7 2 L, M humanized antibody D3H44 antigen-binding fragment 10090  
728 1FGN 1 L IMMUNOGLOBULIN FAB 5G9 A MONOCLONAL FAB AGAINST HUMAN TISSUE FACTOR LIGHT CHAIN RESIDUES 1 - 214, HEAVY CHAIN RESIDUES 1 - 214 10090  
729 2HFG 1 L CB3s Fab light chain (kappa) 9606  
730 3CFJ 1 A, C, E, L CATALYTIC ANTIBODY FAB 34E4 LIGHT CHAIN FUSION PROTEIN OF THE VARIABLE DOMAIN (AUTHOR RESIDUES 1-105) AND THE CONSTANT DOMAIN (UNP RESIDUES 131-239) 10090  
731 2MPA 1 L PROTEIN (MN12H2 IGG2A-KAPPA) FAB FRAGMENT 10090  
732 3GKW 2 L Light chain of the antibody Nimotuzumab 9606  
733 2A1W 1 L, M immunoglobulin light chain kappa Fab fragment, light chain 10090  
734 3JWD 3 L, O FAB 48D LIGHT CHAIN 9606  
735 3O0R 1 L antibody fab fragment light chain 10090  
736 4JQI 3 L Fab30 light chain 10090  
737 1FAI 1 L IGG2B-KAPPA R19.9 FAB (LIGHT CHAIN) 10090  
738 3SKJ 1 L, M Antibody, light chain 9606  
739 3U30 2 B, E Light chain Fab 9606  
740 3QCV 2 L, M LT3015 antibody Fab fragment, light chain 9606  
741 1M7I 1 A light chain of the monoclonal antibody Fab SYA/J6 10090  
742 3U0T 1 A, C ponezumab LC Fab 9606  
743 1C12 1 A PROTEIN (ANTIBODY FRAGMENT FAB) 10090  
744 1KB5 3 L ANTIBODY DESIRE-1 CLEAVED BY PAPAIN FAB 10090  
745 3ZDZ 4 F, L 10E5 FAB LIGHT CHAIN 10090  
746 2VDN 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
747 1MF2 1 L, M MONOCLONAL ANTIBODY F11.2.32 FAB FRAGMENT 10090  
748 3FO0 1 L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090  
749 1TQB 3 C VRQ14 Fab light chain VRQ14 Fab fragment 10090  
750 4LCU 2 B Fab heavy chain 10090  
751 3L7F 1 A, D, L H2L6 LIGHT CHAIN 9606  
752 2FJF 1 A, C, E, G, J, L, M, O, Q, S, U, W Light Chain of a VEGF binding Antibody 9606  
753 1LO4 1 L If kappa light chain Fab fragment 10090  
754 1IGF 1 L, M IGG1-KAPPA B13I2 FAB (LIGHT CHAIN) 10090  
755 1WCB 1 A, L FAB FRAGMENT OF CATALYTIC ANTIBODY 15A9, LIGHT CHAIN 10090  
756 2VDM 4 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
757 4ENE 3 D, F light chain of Fab fragment 10090  
758 2BDN 2 L Antibody light chain 11K2 fab fragment 10090  
759 2F19 1 L IGG2B-KAPPA R19.9 FAB (LIGHT CHAIN) 10090  
760 2NYY 2 C CR1 monoclonal antibody light chain 9606  
761 3CLE 1 L Fab light chain 10090  
762 2GCY 1 A huC25 fab fragment light chain 10090  
763 4OCY 2 L Fab ADD058 Light Chain 10090  
764 4JLR 2 B, L Motavizumab Fab light chain 9606  
765 2QQK 3 L Antibody Light Chain 9606  
766 4J1U 1 A, C, E antibody 93F3 Light chain 10090  
767 2PW2 1 A 2F5 Fab' heavy chain 9606  
768 1ZTX 3 L Light Chain of E16 Antibody VL and CL Domains 10090  
769 3NGB 3 C, F, K, L Antigen binding fragment of light chain: Antibody VRC01 9606  
770 3IJS 1 A, C Immunoglobulin light chain (IGG3) 10090  
771 1I9I 1 L RECOMBINANT MONOCLONAL ANTI-TESTOSTERONE FAB FRAGMENT LIGHT CHAIN 10090  
772 2J88 3 L FAB 10090  
773 2GK0 1 A, L Catalytic elimination antibody 13G5 light chain Fab fragment 10090  
774 2F58 1 L PROTEIN (IGG1 FAB 58.2 ANTIBODY (LIGHT CHAIN)) FAB FRAGMENT 10090  
775 1H3P 2 L ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
776 4CAD 1 A, D, G, J ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
777 1N8Z 1 A Herceptin Fab (antibody) - light chain 10090  
778 2PW1 1 A 2F5 Fab fragment heavy chain 9606  
779 4OAW 1 A, C Light chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158 9606  
780 3OR7 2 B antibody fab fragment light chain 10090  
781 1TPX 3 C the VRQ14 Fab residues (1-214) 10090  
782 3I02 1 A, C Immunoglobulin light chain S54-10 Fab light chain 10090  
783 3BT2 3 L anti-uPAR antibody, light chain Fab fragment, light chain 10090  
784 2R2E 1 A Fab, antibody fragment (IgG1k), light chain 10090  
785 1TZH 2 A, L Fab YADS1 Light Chain 10090  
786 4JZJ 3 B, L Fab Light Chain 10090  
787 1RMF 1 L IGG2A-KAPPA R6.5 FAB (LIGHT CHAIN) 10090  
788 1GGI 1 L, M IGG2A 50.1 FAB (LIGHT CHAIN) 10090  
789 1MNU 1 L PROTEIN (IGG2A-KAPPA ANTIBODY MN12H2 (LIGHT CHAIN)) FAB FRAGMENT 10090  
790 1JHK 1 L Ig kappa-chain 10090  
791 4M6O 1 L CNTO7309 light chain 9606  
792 4IJ3 2 B Light chain of FAB fragment 10090  
793 3QEH 2 B, D, F, H Fab fragment of human anti-HIV-1 Env antibody N12-i15,light chain Fab light chain 9606  
794 4OLW 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
795 3RPI 1 B, L Light chain from highly potent anti-HIV neutralizing antibody 9606  
796 1FRG 1 L IGG2A 26/9 FAB (LIGHT CHAIN) 10090  
797 1GGC 1 L IGG2A-KAPPA 50.1 FAB (LIGHT CHAIN) 10090  
798 1BBD 1 L IGG2A-KAPPA 8F5 FAB (LIGHT CHAIN) 10090  
799 1T4K 1 A, C IMMUNOGLOBULIN IGG1, KAPPA LIGHT CHAIN antibody FAB 93f3 10090  
800 3G5Z 1 A 175 light chain 10090  
801 4DVR 2 L Fab 48d Light chain 9606  
802 3EYQ 1 C M2J5 Fab 9606  
803 1CGS 1 L IGG2B-KAPPA NC6.8 FAB (LIGHT CHAIN) 10090  
804 1V7M 1 L, M Monoclonal TN1 Fab Light Chain Fab Light Chain 10090  
805 1ND0 1 A, C, E, G IMMUNOGLOBULIN IGG2A IMMUNOGLOBULIN FAB FRAGMENT, light chain 10090  
806 3WFB 1 L antibody fab fragment light chain 10090  
807 2O5Y 1 L chimeric antibody Fab 1E9-DB3 light chain 10090  
808 2Z91 2 B, D Anti-ciguatoxin antibody 10C9 FAB light chain 10090  
809 3HI5 2 L light chain of Fab fragment of AL-57 against alpha L I domain 9606  
810 2AAB 1 L anti-idiotypic monoclonal antibody (light chain) 10090  
811 4F37 3 K, L Fab WO2 anti-amyloid-beta antibody Fab fragment 10090  
812 3QG7 2 L AP4-24H11 Antibody Light Chain 10090  
813 3PHO 1 A S64-4 Fab (IgG1) light chain 10090  
814 3CFK 1 A, C, E, G, J, L, M, O CATALYTIC ANTIBODY FAB 34E4 LIGHT CHAIN FUSION PROTEIN OF THE VARIABLE DOMAIN (AUTHOR RESIDUES 1-105) AND THE CONSTANT DOMAIN (UNP RESIDUES 131-239) 10090  
815 3VG9 2 B antibody fab fragment light chain 10090  
816 2GJZ 1 A, L Catalytic elimination antibody 13G5 light chain Fab fragment 10090  
817 1A5F 1 L MONOCLONAL ANTI-E-SELECTIN 7A9 ANTIBODY (LIGHT CHAIN) FAB FRAGMENT 10090  
818 1NSN 1 L IGG FAB (IGG1, KAPPA) 10090  
819 2OJZ 1 L, M Fab ED10 light chain 10090  
820 2ATK 2 B ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
821 1CLY 1 L IGG FAB (HUMAN IGG1, KAPPA) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER CHIMERIC FRAGMENT (BR96) 9606  
822 4GW4 1 B, L 3BNC60 Fab Light-chain 9606  
823 2NLJ 1 A antibody Fab fragment light chain 10090  
824 1YYL 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606  
825 1U8L 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
826 2OZ4 2 L FAB FRAGMENT LIGHT CHAIN 10090  
827 1IBG 1 L IGG2B-KAPPA 40-50 FAB (LIGHT CHAIN) 10090  
828 2NY6 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
829 1EO8 3 L ANTIBODY (LIGHT CHAIN) FAB FRAGMENT OF ANTIBODY BH151 10090  
830 4KPH 1 L, M N62 light chain 10090  
831 3DVG 1 A Human IgG1 fab fragment light chain 9606  
832 4I9W 2 D, F ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
833 1KCR 1 L PC283 IMMUNOGLOBULIN light chain 10090  
834 1GHF 1 L ANTI-ANTI-IDIOTYPE GH1002 FAB FRAGMENT 10090  
835 1DBB 1 L IGG1-KAPPA DB3 FAB (LIGHT CHAIN) 10090  
836 1CLZ 1 L IGG FAB (IGG3, KAPPA) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER FRAGMENT (MBR96) 10090  
837 4HS8 3 L antibody hu5B3.v2 Fab light chain 9606  
838 2AGJ 1 L Yvo Fab, Light Chain 9606  
839 1N64 1 L Fab 19D9D6 light chain 10090  
840 3I2C 1 L CNTO4088 LIGHT CHAIN 10090  
841 4JKP 3 L Light chain of antibody 45-46M2 9606  
842 1FN4 1 A, C MONOCLONAL ANTIBODY AGAINST ACETYLCHOLINE RECEPTOR 10116  
843 1QFU 3 L PROTEIN (IMMUNOGLOBULIN IGG1-KAPPA ANTIBODY (LIGHT CHAIN)) FAB FRAGMENT 10090  
844 3EYO 1 A, C 8f9 Fab 9606  
845 2G2R 1 A, L Green-fluorescent antibody (11G10)-light chain 10090  
846 1B6D 1 A, B IMMUNOGLOBULIN IMMUNOGLOBULIN LIGHT-CHAIN DIMER 9606  
847 3Q3G 1 A, C, F, J Antibody Light Chain 10090  
848 3ZE1 4 F, L 10E5 FAB LIGHT CHAIN 10090  
849 3NFS 1 L Heavy chain of Fab fragment of daclizumab 9606  
850 3B2U 1 D, G, K, L, O, R, U, X IMC-11F8 Fab Light chain 9606  
851 4DN4 1 L CNTO888 LIGHT CHAIN 9606  
852 2FGW 1 L H52 FAB (LIGHT CHAIN) 9606  
853 4DGI 3 L POM1 Fab Light chain 10090  
854 3F58 1 L PROTEIN (IMMUNOGLOBULIN GAMMA I (58.2)) LIGHT CHAIN OF FAB 10090  
855 1GGB 1 L IGG2A-KAPPA 50.1 FAB (LIGHT CHAIN) 10090  
856 1B2W 1 L PROTEIN (ANTIBODY (LIGHT CHAIN)) V DOMAIN AND C DOMAIN 10090  
857 2FJG 2 A, L Fab light chain 9606  
858 1DBJ 1 L IGG1-KAPPA DB3 FAB (LIGHT CHAIN) 10090  
859 1YMH 1 A, C Fab 16D9D6, light chain 10090  
860 4DKF 3 L, M FAb2 Light Chain 9606  
861 1UWE 2 L, U, X ANTIBODY 14D9 FAB LIGHT CHAIN, RESIDUES 1-212 10090  
862 1HEZ 1 A, C KAPPA LIGHT CHAIN OF IG 1-214 9606  
863 4FAB 1 L IGG2A-KAPPA 4-4-20 FAB (LIGHT CHAIN) 10090  
864 1IT9 1 L HUMANIZED ANTIBODY HFE7A, LIGHT CHAIN FAB FRAGMENT 10090  
865 1DBA 1 L IGG1-KAPPA DB3 FAB (LIGHT CHAIN) 10090  
866 2DWE 2 B ANTIBODY FAB LIGHT CHAIN 10090  
867 4GAJ 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090  
868 3EFD 1 L FabL 10090  
869 4JR9 3 L Immunoglobulin Kappa, Light chain 10090  
870 4LF3 1 A, D Fab heavy chain 10090  
871 3STZ 2 B antibody Fab fragment light chain 10090  
872 2A6I 1 A Germline antibody 36-65 Fab light chain Fab 10090  
873 3ZE0 4 F, L 10E5 FAB LIGHT CHAIN 10090  
874 1PSK 1 L ANTIBODY FAB 10090  
875 3VW3 1 L Anti-(6-4) photoproduct antibody 64M-5 Fab (light chain) 10090  
876 3GI9 1 L 7F11 Anti-ApcT Monoclonal Fab Light Chain 10090  
877 1DBM 1 L IGG1-KAPPA DB3 FAB (LIGHT CHAIN) 10090  
878 3RA7 1 L, M Fab fragment, light chain 10090  
879 1B4J 1 L ANTIBODY V DOMAIN AND C DOMAIN 9606  
880 1UWG 2 L, X ANTIBODY 14D9 CATALYTIC ANTIBODY 19C9 FAB LIGHT CHAIN, RESIDUES 1-213 10090  
881 4JPV 3 L LIGHT CHAIN OF ANTIBODY 3BNC117 9606  
882 1CL7 1 L PROTEIN (IGG1 ANTIBODY 1696 (light chain)) FAB 10090  
883 1BAF 1 L IGG1-KAPPA AN02 FAB (LIGHT CHAIN) 10090  
884 4LEO 2 B RG7116 Fab light chain 10090  
885 4G7Y 2 L Fragment antibody light chain 9606  
886 1BLN 1 A, C PROTEIN (MONOCLONAL ANTIBODY MRK-16 (LIGHT CHAIN)) FAB 10090  
887 1IGT 1 A, C IGG2A INTACT ANTIBODY - MAB231 10090  
888 4PY8 4 J antibody 3.1 light chain Fab 9606  
889 3SDY 4 L Antibody CR8020, Light Chain 9606  
890 3DVN 1 A, L Human IgG1 fab fragment light chain 9606  
891 3IXT 1 B, L Motavizumab Fab light chain 10090  
892 2P8M 1 A nmAb 2F5, light chain 9606  
893 4I3R 3 L Light chain of VRC-PG04 Fab 9606  
894 4NP4 3 L, M bezlotoxumab light chain 9606  
895 2ADI 1 A Q425 Fab Light chain 10090  
896 1FJ1 1 A, C HYBRIDOMA ANTIBODY LA2 (LIGHT CHAIN) FAB FRAGMENT 10090  
897 3UC0 3 L, M Light chain, monoclonal antibody 5H2 Fab 9598  
898 2ZCH 2 L monoclonal antibody 8G8F5 Fab 10090  
899 1FH5 1 L MONOCLONAL ANTIBODY MAK33 FAB LIGHT CHAIN 9606  
900 1NLD 1 L FAB1583 10090  
901 4M7Z 2 C, L S25-26 Fab (Igg1k) Light Chain 10090  
902 3IKC 1 A, C Immunoglobulin light chain (IGG3) 10090  
903 1BBJ 1 A, L IGG4-KAPPA B72.3 FAB (LIGHT CHAIN) 10090  
904 3BKY 2 L the Fab fragment of chimeric 2H7, light chain 10090  
905 4ERS 1 L Fab light chain 9606  
906 2OSL 1 B, L light chain of the Rituximab Fab fragment The protein was produced as a chimeric fab fragment. residues 1-106 is from murine and 107-213 is from human. 10090  
907 3O45 1 B, L Mouse monoclonal antibody 101F 101F Fab light chain 10090  
908 1HQ4 1 A, C ANTIBODY HA5-19A4 FAB LIGHT CHAIN VARIABLE REGIONS OF FAB LIGHT AND HEAVY CHAINS 10090  
909 1DEE 1 A, C, E IGM RF 2A2 FAB LIGHT CHAIN 9606  
910 1MCP 1 L IGA-KAPPA MCPC603 FAB (LIGHT CHAIN) 10090  
911 4HC1 3 L, N 10G3 light chain 10090  
912 1HIM 1 H, J IGG2A-KAPPA 17/9 FAB (HEAVY CHAIN) 10090  
913 4MWF 2 B, L Fab AR3C light chain 9606  
914 3OR6 2 B antibody fab fragment light chain 10090  
915 2WUC 5 L FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606  
916 3SQO 3 L J16 Light chain 9606  
917 4FFV 2 C, L 11A19 Fab light chain 10090  
918 4K3J 4 L Onartuzumab Fab light chain 10090  
919 1ZWI 2 B monoclonal antibody light chain 10090  
920 2DWD 2 B ANTIBODY FAB LIGHT CHAIN 10090  
921 2VC2 4 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
922 1FBI 1 L, P IGG1 F9.13.7 FAB (LIGHT CHAIN) 10090  
923 4C83 2 B, D LPT3 LIGHT CHAIN 10090  
924 4PS4 1 L M1295 LIGHT CHAIN 9606  
925 2A6J 1 A, L Germline antibody 36-65 Fab light chain Fab 10090  
926 1F11 1 A, C F124 IMMUNOGLOBULIN (KAPPA LIGHT CHAIN) FAB FRAGMENT 10090  
927 1Y18 1 A, C, E, L Catalytic antibody 34E4 light chain The variable domain (residues 1-107) is from a murine source and the constant domain (108-214) is from a human source 10090  
928 1YY9 2 C Cetuximab Fab Light chain 10090  
929 2HVJ 2 B antibody Fab light chain 10090  
930 4AG4 3 L MONOCLONAL ANTIBODY 3E3 LIGHT CHAIN MONOCLONAL ANTIBODY AGAINST HUMAN DDR1 10090  
931 3NZ8 2 B, L Mouse anti V3 antibody 7C8 Fab, light chain Fab 10090  
932 1HZH 2 L, M IMMUNOGLOBULIN LIGHT CHAIN 9606  
933 3HI1 2 A, L F105 Light Chain 9606  
934 4PY7 2 B, J antibody 3.1 light chain Fab 9606  
935 2BOB 2 B ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
936 4K8R 3 C Fab1, light chain 9606  
937 1RZK 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606  
938 2DBL 1 L IGG1-KAPPA DB3 FAB (LIGHT CHAIN) 10090  
939 1ZLU 1 K, L FAB 2G12, light chain FAB, Light Chain 9606  
940 1BOG 1 A ANTIBODY (CB 4-1) FAB DERIVED FROM IGG2A KAPPA FAB FRAGMENT 10090  
941 1G9N 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
942 3QA3 1 A, C, F, J Antibody Light chain 10090  
943 2MCP 1 L IGA-KAPPA MCPC603 FAB (LIGHT CHAIN) 10090  
944 4KK8 3 D, F Fab, light chain 10090  
945 1TZI 1 A Fab YADS2 Light Chain 10090  
946 3LD8 2 B antibody Fab fragment light chain 10032  
947 1QLR 1 A, C IGM KAPPA CHAIN V-III (KAU COLD AGGLUTININ) FAB FRAGMENT 9606  
948 4KUZ 1 L antibody 4A5 light chain Fab (mouse variable domain, human constant domain) 10090  
949 1EGJ 2 L ANTIBODY (LIGHT CHAIN) 10090  
950 1AI1 1 L IGG1-KAPPA 59.1 FAB (LIGHT CHAIN) 10090  
951 2IGF 1 L IGG1-KAPPA B13I2 FAB (LIGHT CHAIN) 10090  
952 4KRP 3 C Cetuximab light chain Fab 10090  
953 1CFQ 1 A PROTEIN (IGG2A KAPPA ANTIBODY CB41 (LIGHT CHAIN)) FAB 10090  
954 1XGY 1 L, M K42-41L Fab Light Chain Anitgen Binding Fragment, Fab 10090  
955 4JPW 3 L LIGHT CHAIN OF ANTIBODY 12A21 9606  
956 2QSC 1 L Fab F425-B4e8, Light chain Light chain 9606  
957 1TQC 3 C VRQ14 Fab light chain VRQ14 Fab fragment 10090  
958 1MHP 3 L, Y FAB FRAGMENT, light chain 10090  
959 4N9G 2 B, F, L, N Antibody 17HD9, Light Chain 9544  
960 4JB9 3 L antibody VRC06 light chain 9606  
961 2W9E 3 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090  
962 1IAI 1 L IDIOTYPIC FAB 730.1.4 (IGG1) OF VIRUS NEUTRALIZING ANTIBODY 10090  
963 1IAI 3 M ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) 10090  
964 3VI3 3 E, L SG/19 Fab fragment (Light chain) 10090  
965 1OTS 3 D, F Fab fragment (light chain) 10090  
966 3U9P 3 L, M Monoclonal Fab Fragment Light Chain 10116  
967 3O11 1 A, L C706 LIGHT CHAIN variable region, Ig kappa chain C region chimera 10090  
968 1M71 1 A light chain of the monoclonal antibody Fab SYA/J6 10090  
969 1FL6 1 A, L ANTIBODY GERMLINE PRECURSOR TO 28B4 LIGHT CHAIN (CHAINS L AND A) 10090  
970 3CK0 1 L PROTEIN (IMMUNOGLOBULIN; LIGHT CHAIN) IGG1, KAPPA FAB FRAGMENT 10090  
971 1XCT 2 A, C Monoclonal antibody 19D9D6 Light chain 10090  
972 3R1G 3 L FAB of YW412.8.31 antibody light chain 9606  
973 2QQL 3 L Antibody Light Chain 9606  
974 3B9K 1 C, L Fab Heavy Chain Fab Fragment 10117  
975 2P8P 1 A nmAb 2F5, light chain 9606  
976 4AM0 2 B, D, F, L FAB 2H12, LIGHT CHAIN 10090  
977 2ADJ 1 A Q425 Fab Light chain 10090  
978 4MXV 2 E, L, X anti-Lymphotoxin alpha antibody light chain Fab 9606  
979 1CFS 1 A PROTEIN (IGG2A KAPPA ANTIBODY CB41 (LIGHT CHAIN)) FAB 10090  
980 4JRE 3 C, L Immunoglobulin Kappa, Light chain 10090  
981 3WD5 2 L Adalimumab Light Chain 9606  
982 2GSI 1 A, C, E, G Immunoglobulin (kappa) light chain 10090  
983 3EOA 1 A, L Efalizumab Fab fragment, light chain 9606  
984 4GMS 3 L, M, N Fab S139/1 light chain 10090  
985 4GAY 2 B, L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN Fab fragment of AP33 light chain 10090  
986 2J5L 2 B FAB FRAGMENT OF MONOCLONAL ANTIBODY F8.12.19 MONOCLONAL ANTIBODY ISOTYPE IS IGG1, KAPPA ANTIGEN-BINDING FRAGMENT FAB, LIGHT CHAIN 10090  
987 3GI8 2 L 7F11 Anti-ApcT Monoclonal Fab Light Chain 10090  
988 3OPZ 3 L, M, N light chain of the Fab fragment of immunoglobulin G 10090  
989 2ITD 2 B antibody Fab fragment light chain 10090  
990 1V7N 1 L, M, N, O Monoclonal TN1 Fab Light Chain Fab Light Chain 10090  
991 2HH0 1 L Light Chain, P-Clone Fab, Chimera 2-109 (mouse), 110-271 (human) 10090  
992 2WUB 4 L, Q FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606  
993 3U46 2 B, L CH02 Light chain Fab 9606  
994 3IU3 2 B, D, L Light chain of Fab fragment of Basiliximab 10090  
995 1JNL 1 L monoclonal anti-estradiol 17E12E5 immunoglobulin kappa chain 10090  
996 3VI4 3 E, L SG/19 Fab fragment (Light chain) 10090  
997 4HZL 2 B, L Fab light chain 10090  
998 4KY1 1 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN muHP1/2 CDRs + human kappa B3 germline VL framework 9606  
999 1ZLW 1 K, L FAB 2G12, light chain FAB, Light Chain 9606  
1000 4HFU 4 L Fab 8M2 light chain 9606  
 
Sequence Clusters for the Sequence Entities in PDB 3TCL
Entity #1: Chains: A,H - CH04 Heavy Chain Fab protein, length: 237 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 1 3 11055
95% 1 3 10659
90% 1 3 10505
70% 245 1480 2
50% 499 3070 1
40% 499 3071 1
30% 540 3629 1
Entity #2: Chains: B,L - CH04 Light Chain Fab protein, length: 215 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 1 1 30209
95% 1 1 23268
90% 52 365 4
70% 204 1291 3
50% 500 3070 1
40% 500 3071 1
30% 541 3629 1
 

Documentation

Click here for more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB.